These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22491823)

  • 1. An antibody fusion protein for cancer immunotherapy mimicking IL-15 trans-presentation at the tumor site.
    Kermer V; Baum V; Hornig N; Kontermann RE; Müller D
    Mol Cancer Ther; 2012 Jun; 11(6):1279-88. PubMed ID: 22491823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining antibody-directed presentation of IL-15 and 4-1BBL in a trifunctional fusion protein for cancer immunotherapy.
    Kermer V; Hornig N; Harder M; Bondarieva A; Kontermann RE; Müller D
    Mol Cancer Ther; 2014 Jan; 13(1):112-21. PubMed ID: 24198185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-specific crosslinking of GITR as costimulation for immunotherapy.
    Burckhart T; Thiel M; Nishikawa H; Wüest T; Müller D; Zippelius A; Ritter G; Old L; Shiku H; Renner C
    J Immunother; 2010; 33(9):925-34. PubMed ID: 20948444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of a bispecific antibody and costimulatory antibody-ligand fusion proteins for targeted cancer immunotherapy.
    Hornig N; Kermer V; Frey K; Diebolder P; Kontermann RE; Müller D
    J Immunother; 2012 Jun; 35(5):418-29. PubMed ID: 22576347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL15-Based Trifunctional Antibody-Fusion Proteins with Costimulatory TNF-Superfamily Ligands in the Single-Chain Format for Cancer Immunotherapy.
    Beha N; Harder M; Ring S; Kontermann RE; Müller D
    Mol Cancer Ther; 2019 Jul; 18(7):1278-1288. PubMed ID: 31040163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
    Kakarla S; Chow KK; Mata M; Shaffer DR; Song XT; Wu MF; Liu H; Wang LL; Rowley DR; Pfizenmaier K; Gottschalk S
    Mol Ther; 2013 Aug; 21(8):1611-20. PubMed ID: 23732988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screens.
    Zhang J; Valianou M; Simmons H; Robinson MK; Lee HO; Mullins SR; Marasco WA; Adams GP; Weiner LM; Cheng JD
    FASEB J; 2013 Feb; 27(2):581-9. PubMed ID: 23104982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Nanocage Mediated Fibroblast-Activation Protein Targeted Photoimmunotherapy To Enhance Cytotoxic T Cell Infiltration and Tumor Control.
    Zhen Z; Tang W; Wang M; Zhou S; Wang H; Wu Z; Hao Z; Li Z; Liu L; Xie J
    Nano Lett; 2017 Feb; 17(2):862-869. PubMed ID: 28027646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bispecific single-chain diabody-immunoliposomes targeting endoglin (CD105) and fibroblast activation protein (FAP) simultaneously.
    Rabenhold M; Steiniger F; Fahr A; Kontermann RE; Rüger R
    J Control Release; 2015 Mar; 201():56-67. PubMed ID: 25617725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapy.
    Liu M; Wang H; Liu L; Wang B; Sun G
    J Transl Med; 2016 Jun; 14(1):155. PubMed ID: 27246873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor targeting of the IL-15 superagonist RLI by an anti-GD2 antibody strongly enhances its antitumor potency.
    Vincent M; Bessard A; Cochonneau D; Teppaz G; Solé V; Maillasson M; Birklé S; Garrigue-Antar L; Quéméner A; Jacques Y
    Int J Cancer; 2013 Aug; 133(3):757-65. PubMed ID: 23354868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8.
    Bauer S; Adrian N; Siebenborn U; Fadle N; Plesko M; Fischer E; Wüest T; Stenner F; Mertens JC; Knuth A; Ritter G; Old LJ; Renner C
    Cancer Immun; 2009 Mar; 9():2. PubMed ID: 19267427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-15.IL-15Rα complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells.
    Tamzalit F; Barbieux I; Plet A; Heim J; Nedellec S; Morisseau S; Jacques Y; Mortier E
    Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8565-70. PubMed ID: 24912180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and characterization of a protein superagonist of IL-15 fused with IL-15Rα and a high-affinity T cell receptor.
    Stone JD; Chervin AS; Schreiber H; Kranz DM
    Biotechnol Prog; 2012; 28(6):1588-97. PubMed ID: 22961781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of IL-15/IL-15Rα sushi domain-IgG4 Fc complexes in Pichia pastoris with potent activities and prolonged half-lives.
    Xu H; Shi M; Shao C; Li H; Wu J; Yu Y; Fang F; Guo Y; Xiao W
    Microb Cell Fact; 2021 Jun; 20(1):115. PubMed ID: 34107983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted bioactivity of membrane-anchored TNF by an antibody-derived TNF fusion protein.
    Bauer S; Adrian N; Williamson B; Panousis C; Fadle N; Smerd J; Fettah I; Scott AM; Pfreundschuh M; Renner C
    J Immunol; 2004 Mar; 172(6):3930-9. PubMed ID: 15004201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-15/IL-15Rα Heterodimeric Complex as Cancer Immunotherapy in Murine Breast Cancer Models.
    Guo S; Smeltz RB; Nanajian A; Heller R
    Front Immunol; 2020; 11():614667. PubMed ID: 33628206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of a dual cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM expressing tumor cells.
    Schanzer JM; Fichtner I; Baeuerle PA; Kufer P
    J Immunother; 2006; 29(5):477-88. PubMed ID: 16971804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action.
    Dubois S; Patel HJ; Zhang M; Waldmann TA; Müller JR
    J Immunol; 2008 Feb; 180(4):2099-106. PubMed ID: 18250415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation.
    Wu Z; Xu Y
    J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.